Home > Insider Trading > Filing (0001179110-18-005561)

Filing Details

Accession Number:: 0001179110-18-005561
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2018-04-10 18:10:44
Reporting Period:: 2018-03-07

Accepted Time:: 2018-04-10 18:10:44
Original Submission Date:: 2018-03-08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651561	Tabula Rasa Healthcare Inc.	TRHC	Services-Business Services, Nec (7389)	465726437

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1685832	V Orsula Knowlton	228 Strawbridge Drive Suite 100 Moorestown NJ 08057	President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-03-07	3,129	$35.37	908,480	No	4	S	Indirect	Held by spouse.
Common Stock	Disposition	2018-03-07	4,871	$35.73	903,609	No	4	S	Indirect	Held by spouse.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by spouse.
No	4	S	Indirect	Held by spouse.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	887,641	Direct

Footnotes

This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Calvin H. Knowlton on December 4, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.81 to $35.69, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $35.70 to $35.84, inclusive.
Previous disclosure stated that the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 was 829,443. Notwithstanding the foregoing, the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 is 908,480.
Previous disclosure stated that the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 was 824,572. Notwithstanding the foregoing, the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 is 903,609.
Previous disclosure stated that the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 was 821,907. Notwithstanding the foregoing, the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 is 887,641.